Feb 26, 2025 | Insights
Persei vivarium participates, once again, in the internationally renowned IBD congress, ECCO’25, promoting the UR-CARE and E-QUALITY projects by Patricia Domínguez, February 26, 2025 The days from February 19 to 22 marked an important date for the global scientific...
Feb 5, 2025 | Insights
Decentralized Clinical Trials in Oncology: What benefits do they provide? by Pedro Vergara, February 5, 2025 Clinical research is one of the fundamental pillars of medicine that enables us to better understand diseases and to develop safe and effective therapies for...
Jan 22, 2025 | Insights
The future of Digital Therapeutics (DTx): Perspectives and market projections by Ana Díaz-Roncero, January 22, 2025 Digital Therapeutics (DTx), clinically evaluated software designed to prevent, diagnose, or treat diseases, are transforming healthcare. These tools...
Dec 11, 2024 | Insights
Evolution of Digital Health: What has changed and what do we expect? by Pedro Vergara, December 11, 2024 The COVID-19 pandemic created a “before” and an “after” in many areas, without a doubt including Digital Health. The pandemic conditions promoted telemedicine,...
Oct 30, 2024 | Insights
What are the benefits of fast-track approval for Digital Therapeutics (DTx)? by Pedro Vergara, October 30, 2024 As we have seen, Digital Therapeutics (DTX) go one step beyond Digital Health tools, becoming clinically validated solutions that meet the technical...
Oct 2, 2024 | Insights
What can Digital Health do in Oncology? by Ana Díaz-Roncero and Patricia Domínguez, October 2, 2024 For many years, cancer has been one of the largest and most significant categories of disease around the world. In 2020, 18.1 million new cases of cancer were diagnosed...
